SURVYR

CLBT

Cellebrite DI Ltd.
$11.93
−$0.30 (2.45%)Oct 27 close
Technology CompareTechnicals
-48%-32%-17%-1%+15%Oct 2025Oct 2026Apr 202652w high $19.9852w low $9.58
CLBTSPY
Wall St. Highest PT $20.00 (+67.6%) Wall St. Avg PT $15.36 (+28.7%)
$10$15$19$23$27POC $14Hi $20Avg $15
Underwater Drawdown %Max DD -45.9%Current -38.1%
0.0%-45.9%
Relative Strength vs SPY-49.0% vs SPYUnderperforming
+66%0%-66%
1W
+$0.56 (4.93%)
1M
+$1.14 (10.57%)
3M
−$2.92 (19.66%)
6M
−$0.75 (5.91%)
YTD
−$6.10 (33.83%)
1Y
−$6.57 (35.51%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Strong Buy
7 analysts · mean score 1.25
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$11.93
Average target$15.36
+$3.43 (+28.7%) upsideaverage target vs current price
CurrentAverageMedian
Low$12.50
Median$15.36
High$20.00
12-month Wall Street target range
Recent analyst rating changes · 8
Reiterated
2026-09-15 · DA Davidson reiterated Buy on CLBT
Reiterated
2026-08-14 · Lake Street reiterated Buy on CLBT
Reiterated
2026-08-14 · JP Morgan reiterated Overweight on CLBT
Reiterated
2026-08-14 · DA Davidson reiterated Buy on CLBT
Reiterated
2026-08-14 · Needham reiterated Buy on CLBT
Reiterated
2026-08-06 · DA Davidson reiterated Buy on CLBT

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$2.9B
P/E (last 12 months)50.0
P/E (next 12 months, estimated)17.6
52-week range$9.58 – $19.98
Revenue growth (latest quarter vs a year ago)+15.8%
Dividend yieldNo dividend
Analyst consensusStrong Buy (7)
Average analyst price target$15.36 (+29%)

What they do

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze.

Technology · Software - Infrastructure
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for CLBT yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
SURVYR. Long Book
Not in the current book

Earnings & events

CLBT earningsNext report in 16 days
Next report
Thu Nov 12, 2026Before the open
EPS consensus$0.16 range $0.14–$0.17
Revenue consensus$145.9M 8 analysts
Last 4 quarters · EPS vs estimate
Aug 13, 2026$0.11est $0.11−2.5%In line with estimates
May 14, 2026$0.12est $0.10+24.0%Above estimates
Feb 11, 2026$0.14est $0.14+0.5%In line with estimates
Nov 12, 2025$0.14est $0.13+8.5%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-21 18:14:40 ET
24-1125-0225-0525-0825-1126-0226-0526-080.000.14
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$131.1M+15.8%
2026-03-31$128.3M–
2025-12-31$128.8M–
2025-09-30$126.0M–
2025-06-30$113.3M–

News & catalysts

More news
Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
PR Newswire · Oct 21
Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
CNW Group · Oct 21
Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
PR Newswire · Oct 21
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
PR Newswire · Oct 20
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
CNW Group · Oct 20
Rating changes
Reiterated
2026-09-15 · DA Davidson reiterated Buy on CLBT
Reiterated
2026-08-14 · Lake Street reiterated Buy on CLBT
Reiterated
2026-08-14 · JP Morgan reiterated Overweight on CLBT
Reiterated
2026-08-14 · DA Davidson reiterated Buy on CLBT
Reiterated
2026-08-14 · Needham reiterated Buy on CLBT
Reiterated
2026-08-06 · DA Davidson reiterated Buy on CLBT

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
Barter David
Chief Financial Officer · 2026-10-16
Sell
$136.1K
Hogan Thomas E.
Insider · 2026-08-25
Sell
$285.7K
Gee David Nicholas
Chief Marketing Officer · 2026-08-24
Sell
$49.1K
Gee David Nicholas
Chief Marketing Officer · 2026-08-21
Sell
$24.7K
Jewell Marcus
Global Chief Revenue Officer · 2026-08-21
Sell
$141.2K
Gee David Nicholas
Chief Marketing Officer · 2026-08-12
Sell
$3.7K
Jewell Marcus
Global Chief Revenue Officer · 2026-08-12
Sell
$6.6K
Hogan Thomas E.
Director, Chief Executive Officer · 2026-08-12
Sell
$2.1M
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-21 18:14:40 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026